Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma | MicrobiomeTrials← Back to trialsNCT05045027
Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma
RecruitingEARLY_PHASE1INTERVENTIONAL
Trial Details
Start: 2021-09-01Est. Completion: 2023-11-15
Enrollment target: 36 participants Locations- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Other microbiome trials you might be interested in
Optic Pathway Glioma
Infantile optic pathway glioma (OPG) is generally benign and slow-growing, but due to infiltration and compression of se…
Rome, ItalyEst. completion Jun 30, 2027
Brain (Nervous System) Cancers
This research study is for participants with glioblastoma. It can cause a tumor immunosuppression which helps myeloid ce…
Cleveland, United StatesEst. completion Dec 17, 2027
Phase 2
Recruiting
This randomized phase II/III trial studies how well temozolomide and veliparib work compared to temozolomide alone in tr…
Birmingham, United StatesEst. completion Dec 1, 2021